718 related articles for article (PubMed ID: 30008018)
1. Plasma microRNAs as biomarkers for Lamin A/C-related dilated cardiomyopathy.
Toro R; Blasco-Turrión S; Morales-Ponce FJ; Gonzalez P; Martínez-Camblor P; López-Granados A; Brugada R; Campuzano O; Pérez-Serra A; Rosa Longobardo F; Mangas A; Llorente-Cortes V; de Gonzalo-Calvo D
J Mol Med (Berl); 2018 Aug; 96(8):845-856. PubMed ID: 30008018
[TBL] [Abstract][Full Text] [Related]
2. Circulating microRNAs as novel biomarkers for dilated cardiomyopathy.
Wang H; Chen F; Tong J; Li Y; Cai J; Wang Y; Li P; Hao Y; Tian W; Lv Y; Chong J; Yang J
Cardiol J; 2017; 24(1):65-73. PubMed ID: 27748501
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of circulating miRNAs as a novel tool to assess BAG3-associated familial dilated cardiomyopathy.
Zaragoza C; Saura M; Hernández I; Ramirez-Carracedo R; García-García F; Zamorano JL; Mangas A; Toro R
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30792263
[TBL] [Abstract][Full Text] [Related]
4. Peripheral microRNA panels to guide the diagnosis of familial cardiomyopathy.
Belmonte T; Mangas A; Calderon-Dominguez M; Quezada-Feijoo M; Ramos M; Campuzano O; Gomez S; Peña ML; Cubillos-Arango AM; Dominguez F; Llorente-Cortés V; de Gonzalo-Calvo D; Toro R
Transl Res; 2020 Apr; 218():1-15. PubMed ID: 32032554
[TBL] [Abstract][Full Text] [Related]
5. Proteomic identification of putative biomarkers for early detection of sudden cardiac death in a family with a LMNA gene mutation causing dilated cardiomyopathy.
Izquierdo I; Rosa I; Bravo SB; Guitián E; Pérez-Serra A; Campuzano O; Brugada R; Mangas A; García Á; Toro R
J Proteomics; 2016 Oct; 148():75-84. PubMed ID: 27457270
[TBL] [Abstract][Full Text] [Related]
6. [Association between LMNA mutation and familial and idiopathic dilated cardiomyopathy patients in Xinjiang].
Sun S; Zhang Y; Zhao J; Zhou X; Wang Y; Tuerxun G; Zhang H; Tang B
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Mar; 42(3):202-7. PubMed ID: 24831476
[TBL] [Abstract][Full Text] [Related]
7. Plasma microrna expression profile for reduced ejection fraction in dilated cardiomyopathy.
Calderon-Dominguez M; Belmonte T; Quezada-Feijoo M; Ramos M; Calderon-Dominguez J; Campuzano O; Mangas A; Toro R
Sci Rep; 2021 Apr; 11(1):7517. PubMed ID: 33824379
[TBL] [Abstract][Full Text] [Related]
8. Circulating MicroRNAs as Potential Molecular Biomarkers for Intracranial Aneurysmal Rupture.
Supriya M; Christopher R; Indira Devi B; Bhat DI; Shukla D
Mol Diagn Ther; 2020 Jun; 24(3):351-364. PubMed ID: 32323261
[TBL] [Abstract][Full Text] [Related]
9. DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated With LMNA (Lamin A/C) Mutations.
Chen SN; Lombardi R; Karmouch J; Tsai JY; Czernuszewicz G; Taylor MRG; Mestroni L; Coarfa C; Gurha P; Marian AJ
Circ Res; 2019 Mar; 124(6):856-873. PubMed ID: 30696354
[TBL] [Abstract][Full Text] [Related]
10. Truncating titin mutations are associated with a mild and treatable form of dilated cardiomyopathy.
Jansweijer JA; Nieuwhof K; Russo F; Hoorntje ET; Jongbloed JD; Lekanne Deprez RH; Postma AV; Bronk M; van Rijsingen IA; de Haij S; Biagini E; van Haelst PL; van Wijngaarden J; van den Berg MP; Wilde AA; Mannens MM; de Boer RA; van Spaendonck-Zwarts KY; van Tintelen JP; Pinto YM
Eur J Heart Fail; 2017 Apr; 19(4):512-521. PubMed ID: 27813223
[TBL] [Abstract][Full Text] [Related]
11. Quantitative expression of the mutated lamin A/C gene in patients with cardiolaminopathy.
Narula N; Favalli V; Tarantino P; Grasso M; Pilotto A; Bellazzi R; Serio A; Gambarin FI; Charron P; Meder B; Pinto Y; Elliott PM; Mogensen J; Bolognesi M; Bollati M; Arbustini E
J Am Coll Cardiol; 2012 Nov; 60(19):1916-20. PubMed ID: 23062543
[TBL] [Abstract][Full Text] [Related]
12. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
[TBL] [Abstract][Full Text] [Related]
13. Genetic mutation of familial dilated cardiomyopathy based on next‑generation semiconductor sequencing.
Lin XF; Luo JW; Liu G; Zhu YB; Jin Z; Lin X
Mol Med Rep; 2018 Nov; 18(5):4271-4280. PubMed ID: 30221713
[TBL] [Abstract][Full Text] [Related]
14. MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM.
Li M; Chen X; Chen L; Chen K; Zhou J; Song J
J Transl Med; 2018 Jun; 16(1):161. PubMed ID: 29885652
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy.
Fan KL; Zhang HF; Shen J; Zhang Q; Li XL
Indian Heart J; 2013; 65(1):12-6. PubMed ID: 23438607
[TBL] [Abstract][Full Text] [Related]
16. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.
van Tintelen JP; Hofstra RM; Katerberg H; Rossenbacker T; Wiesfeld AC; du Marchie Sarvaas GJ; Wilde AA; van Langen IM; Nannenberg EA; van der Kooi AJ; Kraak M; van Gelder IC; van Veldhuisen DJ; Vos Y; van den Berg MP;
Am Heart J; 2007 Dec; 154(6):1130-9. PubMed ID: 18035086
[TBL] [Abstract][Full Text] [Related]
17. Plasma microRNA profiling of children with idiopathic dilated cardiomyopathy.
Enes Coşkun M; Kervancıoğlu M; Öztuzcu S; Yılmaz Coşkun F; Ergün S; Başpınar O; Kılınç M; Temel L; Coşkun MY
Biomarkers; 2016; 21(1):56-61. PubMed ID: 26631154
[TBL] [Abstract][Full Text] [Related]
18. Circulating microRNA as a biomarker for recovery in pediatric dilated cardiomyopathy.
Miyamoto SD; Karimpour-Fard A; Peterson V; Auerbach SR; Stenmark KR; Stauffer BL; Sucharov CC
J Heart Lung Transplant; 2015 May; 34(5):724-33. PubMed ID: 25840506
[TBL] [Abstract][Full Text] [Related]
19. Circulating circRNA as biomarkers for dilated cardiomyopathy etiology.
Costa MC; Calderon-Dominguez M; Mangas A; Campuzano O; Sarquella-Brugada G; Ramos M; Quezada-Feijoo M; Pinilla JMG; Robles-Mezcua A; Del Aguila Pacheco-Cruz G; Belmonte T; Enguita FJ; Toro R
J Mol Med (Berl); 2021 Dec; 99(12):1711-1725. PubMed ID: 34498126
[TBL] [Abstract][Full Text] [Related]
20. Systematic in vivo candidate evaluation uncovers therapeutic targets for LMNA dilated cardiomyopathy and risk of Lamin A toxicity.
Tan CY; Chan PS; Tan H; Tan SW; Lee CJM; Wang JW; Ye S; Werner H; Loh YJ; Lee YL; Ackers-Johnson M; Foo RSY; Jiang J
J Transl Med; 2023 Oct; 21(1):690. PubMed ID: 37840136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
